SCIDOT-41. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER

OBJECTIVE: The Sonic Hedgehog (SHH) medulloblastoma subgroup accounts for ~25% of all cases and has an intermediate prognosis. Current conventional therapies result in devastating morbidities including intellectual disability and secondary malignancies. Although molecularly targeted agents that inhi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Kiguchi, Hiroto, Manzari, Mandana, Vaynshteyn, Jake, Gerwin, Jeffrey, Tylawsky, Daniel, Li, Na, Shah, Janki, Shamay, Yosi, Greenblatt, Matthew, Heller, Daniel, Praveen Raju, G
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2019
Предметы:
Abstracts from the 3rd Sno-Scidot Joint Conference on Therapeutic Delivery to the CNS
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846632/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1177
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы